Worlds leading Diagnostic Microbiology Conference | Â America

Theme: Innovation and Excellence-The New Agenda of Diagnostic Microbiology

Diagnostic Microbiology 2017

Diagnostic Microbiology 2017

Conferences Series LLC invites all the participants from all over the world to attend ‘International Conference on Infectious Diseases and Diagnostic Microbiology’ during September 13-14, 2017 in Dallas, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Infectious Diseases and Diagnostic Microbiology’ brings together the global leaders of relevant fields to present their research at this exclusive scientific program. Infectious diseases are disorders caused by micro organisms such as bacteria, fungi, viruses and parasites. Branches of microbiology especially diagnostic and clinical microbiology deals with the cure and prevention of the infectious diseases. Vaccine development is thus of great importance in terms of global health. Recent advancements in Diagnostic Microbiology leads to a great outbreak in disease therapies and thus controlling the emerging and re-emerging microorganisms. Conference highlights will include,Medical microbiology, microbial vaccines, microbial drugs, Types of Infectious Diseases, Infectious Diseases in Plants, Infectious Diseases in Animals Microbial Chemistry of Infectious Diseases, immunology of Diseases, Infectious Diseases & Food Microbiolgy, Infectious Diseases, diagnostic techniques, immunodiagnosis of infectious diseases.

Conferences Series LLC Organizes 300+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 500+ Open access journals which contains over 50,000 eminent personalities, reputed scientists as editorial board members.

Featuring 2 days of Scientific workshop, Special sessions, Speaker & Poster session, Industrial Expo. 300+ attendees from all over the world.

Track 1: Medical Microbiology:

It is a branch of medical science concerned with the prevention, diagnosis and treatment of infectious diseases..Includes the study of microbial pathogenesis and epidemiology and is related to the study of disease. This area of microbiology also focuses on the study of symbiotic and pathogenic microbes. In addition, this field of science studies the clinical uses of microbes for human health. Types of microorganisms that cause infectious disease: fungi, parasites, bacteria and viruses, and also an infectious protein called prion. Certain diagnostic methods help in the accurate diagnosis of the infectious diseases. Some of them are culture techniques, enzyme immunoassays,, microscopic, agglutination and blotting techniquesetc.,

Related Conferences: 7^th World Congress on Clinical Microbiology February 27-28, 2017 Amsterdam, Netherlands, 3^rd World Congress and Expo on Applied Microbiology, Nov 7-9, 2016, DUBAI, UAE, , Global Summit on Tuberculosis and Mycobacteria April 24-26, 2017 Las Vegas, USA, 10^th International Conference On Microbial Engineering May 29-31, 2017 Beijing, China, 8^th World Congress on Virology November 28-30, 2016 San Antonio, USA, International Conference on Fungal Diseases & Control September 25-26, 2017 Dubai, UAE, Annual Conference on Antimicrobials and Drug Resistance August 24-25, 2017 Toronto, Canada, 7^th Annual Congress on Clinical Microbiology August 28-30, 2017 Philadelphia, USA,2^nd International conference on Human Papillomavirus Aug 31-Sep 1, 2017 Philadelphia, USA, Global Veterinary Microbiology Summit & Expo Oct 2-4, 2017 Las Vegas, USA, International Congress on Nosocomial Infections and Health Care October 2-4, Las Vegas, USA Association of Medical Microbiology and Infectious Disease Canada, Association of Medical School Microbiology and Immunology Chairs, Indian Association of Medical Microbiologists & American Society for Microbiology, Infectious Diseases Society of America: IDSA, International Society for Infectious Diseases: ISID, ASID - Australasian Society for Infectious Diseases (ASID).

Track 2: Microbial Vaccines:

Vaccine is a biological preparation that provides active acquired immunity to a particular disease. It is prepared from live or killed forms of the microbe. Vaccinationprevents infectious diseases, responsible for the eradication and restriction of some diseases from much world. Vaccines are also able to induce herd immunity. When the disease causing agent is entered, the body recognizes the protein coat on the virus, and thus is prepared to respond, by (1) nullifying the target agent, (2) perceiving and destroying infected cells before that agent can multiply.

Track 3: Microbial Drugs:

The use of antimicrobial medicines to treat infection is known as antimicrobial chemotherapy. Antimicrobials can be grouped in several ways including spectrum of activity, effect on bacteria and mode of action. Agents that kill harmful microbes are called microbicidal, while those that merely inhibit their growth are called biostatic. The use of antimicrobial medicines to treat infection is known as antimicrobial chemotherapy, while the use of antimicrobial medicines to prevent infection is known as antimicrobial treatment.

Track: 4 Microbial Chemistry:

Microbial metabolism depends on the means by which a microbe obtains the energy and nutrients. It also focuses on the substrate oxidations and dissimilation reactions which is generally used to generate energy. Microbial metabolism is the study of the uptake and usage of the inorganic or organic compounds required for proliferation and nurturing of a cellular steady state Microbes use different types of metabolic approaches and species based on metabolic characteristics

Track: 5: Immunology of Diseases:

The battle between pathogens and the host immune defenses has raged for thousands of years. The immune system has developed a variety of approaches to controlling viral and bacterial infection, which range from direct killing of pathogen to elaborating cytokines that inhibit replication. Pathogens have countered by developing a variety of immune evasion mechanisms. So there is a critical need for new technologies in clinical microbiology, particularly for bloodstream infections, in which associated mortality is among the highest of all infections.

Track: 6: Diagnostic Microbiology:

It is an essential to identify microorganisms and their susceptibility to the antibioticstested. Clinical diagnosis plays a crucial role due to growing resistnace of certain bacteria to antibiotics and introduction of new technologies and automated solutions. Diagnostic tests offer both medical and economic advantages.The development of novel technologies has led to remarkable changes in the role of diagnostics. Faster time-to-results and the detection of disease at the primary stage facilitate patients to receive the well-timed treatment more quickly.

Track: 7:Types of Infectious Diseases:

Infectious diseases are caused by pathogenic microorganisms. The diseases can be spread, directly or indirectly, from one person to another. Zoonotic diseases are infectious diseases of animals that can cause disease when transmitted to humans. Infectious diseases are transmitted in several ways such as airborne, respiratory, food or water, insects, direct contact, indirect contact, fecal-oral and vector transimission.

Hepatitis B, Hepatitis C, Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG), humanpapillomavirus(HPV), Methicillin-resistant Staphylococcus aureus (MRSA), and others (Influenza, Ebola, Typhoid, Malaria, Dengue and Zika) are some of the wide spread infectious diseases in the world. Out of which some of them yet don’t have any known medicine. Based on WHO's statistics, the combination of AIDS,malaria, and tuberculosis is responsible for half (approximately 5 million) of all infectious-disease deaths each year.

Track: 8 Infectious Diseases in Plants:

Organisms that cause infectious diseases in plantsinclude fungi, oomycetes, bacteria, viruses, viroids, virus-like organisms, phytoplasmas, spiroplasms, protozoa, nematodes and parasitic plants. Common pathogenic infection methods are cell wall degrading enzymes, toxins, effector proteins. Control of plant diseases is crucial to the reliable production of food, and it provides significant reductions in agricultural use of land, water, fuel and other inputs. New methods are needed to detect diseases and pests early, such as novel sensors that detect plant odours and spectroscopy and biophotonics that are able to diagnostic plant health and metabolism.

Track: 9:Infectious Diseases in Animals:

Infectious diseases of livestock are a major threat to global animal health and welfare. Zoonotic infections that are transmissible either directly or indirectly between animals and humans are increasing and pose remarkable threats to human health. Influenza A (H1N1), Some emerging diseases such as measles, smallpox, influenza, HIV, diptheria, West Nile virus, tuberculosis, salmonellosis, cat-scratch fever (bartonellosis), legionellosis and cryptosporidiosis are actually much older, but the causative agents were recognized only relatively recently.

Track: 10: Infectious Diseases & Food Microbiology:

Food is an excellent vehicle by which many pathogens (bacteria, viruses/prions and parasites) can reach an appropriate colonisation site in a new host. Although food production practices change, the well-recognised food-borne pathogens, such asSalmonella spp. and Escherichia coli, seem able to evolve to exploit novel opportunities. . Many foodborne parasitic pathogens are known (for example Ascaris, Cryptosporidia and Trichinella) but few of these are effectively monitored in foods, livestock and wildlife The number of food-borne bacteria recognized as being capable of causing human illness has increased in recent years. The emergence of these pathogens has given rise to increased interest in using irradiation as a preservation technique in the food industry. Each year, an estimated 48 million people in the United States experience a foodborne illness. Foodborne illnesses cause about 3,000 deaths in the United States annually.

Track: 11: Diagnostic Techniques :

Current techniques for rapid diagnosis of microbial infections by direct detection of the microbial agent include enzyme immunoassay (EIA) tests, immunofluorescence, latexagglutination assays, and nucleic acid hybridization procedures for the near future, the preferred methods for rapid diagnosis will be by (1) EIA tests utilizing monoclonal antibodies and improved enzyme detection systems, and (2) improved latex agglutination procedures for certain antigens.

Track: 12: Immunodiagnosis of Infectious Diseases:

It is very much important to diagnose the disease even before it becomes serious threat. Technology has many more advancements now a days. In addition, criteria such as environmental stability, ease of production, disease severity, and communicability determine which agents are most likely to be utilized. There are several emerging infectious diseases (ID) with the potential for significant public health consequences, including dengue fever as well as the recent reemergence of zika virus in Brazil. Recent developments in molecular biology techniques have made possible the production of fusion antibody conjugates, which may lead to further improvements in the sensitivity and cost of reagents, as well as possibly revolutionizing the microbial techniques. At the same time, simple-to-use, inexpensive assay systems have been developed with the necessary reliability, accuracy, and sensitivity to bring immunoassay technology to much more diverse areas.

Track:13 Advanced Therapies in Diagnostic Microbiology:

Many advanced therapies have been invented to diagnose the infection. Standard therapies and recent advances have been invented. The treatment options include the use of cyberknives which is the latest molecular diagnostic tool for the treatment ofneoplastic diseases. Recent techniques have proved that there is no disease that cannot be treated. The wonderful cure by antimicrobials shifted the disease trends from infectious to life-style diseases in the developed world. The recent trends in development of antimicrobial resistance are more towards Gram Negative bacteria, although significant resistance is seenwith Gram positive bacteria (MRSA, Clostridiumdifficle) also. Similar reports are seen with Viruses (HIV), parasites (Plasmodiumfalciparum) and several antifungals. These modalities form the hope for the future to curb the development of antimicrobial resistance.

Advances in high-throughput DNA-sequencing techniques have given us the unprecedented ability to rapidly determine the nucleotide sequences of entire bacterial genomes. For some specific applications, microalgae can be considered even a better system than bacteria and fungi. There are several regulatory and ethical issues regarding the safety and efficacy of this therapies . Further research and clinical trials are needed, and more data is required for their approval by US-FDA. These therapies are a new hope to save the humanity from menace of antimicrobial resistance.

The clinical microbiology laboratory has a whole array of diagnostics instruments used for serology, virus culture, and blood culture. Clinical microbiology testing is indispensable for identifying bacterial, fungal, and parasitic infections as well as for preventing epidemics. It also helps in the clinical management of patients. The rapid diagnostic testing market is the most sought after in the microbiology industry as it provides results in less than 30 minutes. Thus, a faster turnaround time (TAT) and immediate results are the major factors that will drive the microbiology market.

The global In Vitro Diagnostics Market is expected to reach $75.1 Billion by 2020, at a CAGR of 5.8% from 2015 to 2020. The global IVD market has evolved over the years with launch of number of innovative techniques having applications across multiple therapeutic areas. Some of the major factors driving the growth of this market are the rising incidences of chronic lifestyle diseases across the globe, growing aging population, and increasing usage of point-of-care testing and personalized medicine. Moreover, a new range of condition-specific markers and tests with advances in genomics and proteomics and increasing investment in emerging countries are creating new opportunities for this market. However, inadequate reimbursement and stringent regulatory approval framework are restraining the growth of this market.

Geographically, North America is the largest regional segment of this market, with a share of ~43% in 2014. The large share of this region can be attributed to the presence of advanced technologies, superlative opportunities for molecular diagnostics in genetic testing and cancer screening, established distribution channels in the region, and the presence of a large number of leading market players such as Abbott Laboratories, Inc., Johnson and Johnson, Becton, Dickson and Company, Danaher Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., and Alere, Inc. (U.S.).

Europe is expected to hold the second-largest share of the global clinical microbiology market in 2016. This prominent market position of the European market is due to factors such as rising acceptance of genome-based diagnostic techniques by healthcare professionals, supportive government policies that ease public accessibility to diagnostic assay procedures (including clinical microbiology), large number of clinical microbiology procedures performed annually across the region, presence of a large number of biotechnology and molecular diagnostic companies, rapid growth in the aging population, and growing incidence of infectious diseases.

Automation has helped to enhance key laboratory performance attributes like consistency, quality, and a slower total turnaround time. Thus, automation is the new trend in the microbiology field. Similarly, factors like the consolidation of diagnostic laboratory chains and the increase in public awareness are driving the growth of the market.

The report ‘Global Microbiology Market forecast for 2018’ analyzes the market by segments such as instruments and reagents. These two segments experienced a positive growth till 2013, with a market value of $3.55 billion, comprising of $2.99 billion for reagents and $0.55 billion for instruments. It is expected to grow at a CAGR of 6.2%.

The U.S. commanded the largest share of 89% in the American microbiology IVD market at $1320.4 million in 2012, and is expected to reach $1715.6 million by 2017, at a CAGR of 5.6% from 2013 to 2018.

Europe holds the second-largest market position. Germany commanded the largest share of 20% at $223.7 million in 2013, and is expected to reach $272.5 million by 2018, at a CAGR of 4.2% from 2013 to 2018.

China commanded the largest share of 53% at $177.1 million in 2013 in the Asian microbiology market, and is expected to reach $334.5 million by 2018, at a CAGR of 14.2% from 2013 to 2018.

Target Audience

Microbiological Testing/Clinical Microbiology product manufacturers
Healthcare service providers (Including hospitals and diagnostic centers)
Pharmaceutical product manufacturing companies
Clinical testing laboratories
Clinical Research Organizations (CROs)
Food and beverages manufacturing companies
Environmental monitoring committees
Environmental monitoring product manufacturing companies
Research laboratories and academic institutes
Market research and consulting firms

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	September 13-14, 2017
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

2^nd International Conference on Infectious Diseases & Diagnostic Microbiology September 13-14, 2017 Dallas, Texas, USA

Recommended Global Microbiology Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Diagnostic Microbiology 2017

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues